Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Belimumab[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[13] 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 95, 222, 296 💬
2Belimumab 1 MG/KG[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
3Belimumab 10 MG[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 222 💬
4Belimumab 10 MG/KG[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[3] 43, 46, 49 💬
5Belimumab 10 MG/KG plus standard therapy[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
6Belimumab 100 MG SC[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
7Belimumab 10MG/KG[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
8Belimumab 200 MG SC[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
9Belimumab 200 MG/ML[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
10Belimumab 4 MG/KG[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
11Belimumab autoinjector[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
12Belimumab FOR IV[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
13Belimumab FOR SC[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
14Belimumab IN SLE patients / rituximab IN RA patients[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[2] 46, 49 💬
15Belimumab injection[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
16Belimumab or benlysta[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
17Belimumab plus early vaccination[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
18Belimumab plus late vaccination[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49 💬
19Belimumab+SOC[1] Belimumab (Belimumab)[1] Belimumab (Belimumab, Belimumab) 💬 [1] TNFSF13B 💬 [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 48 💬
20Combination OF rituximab with subcutaneous belimumab[1] Rituximab[1] Rituximab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 63 💬
21Prednisone and belimumab[1] Prednisone[1] Prednisone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 300 💬
22SC belimumab 200 MG----[1] 49 💬